Difference between revisions of "Part:BBa K3140002"
(4 intermediate revisions by the same user not shown) | |||
Line 15: | Line 15: | ||
PsiK is a native enzyme obtained from ''Psilocybe cubensis'', which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both 4-hydroxytryptamine and psilocin as substrates to yield norbaeocystin ('''Fig. 1''') and psilocybin ('''Fig. 2'''), respectively. In a native state, PsiK is a 362 amino acid protein (40.4 kDa) with a theoretical pI of 5.26 calculated with the ExPASy ProtParam tool<ref name="ExPASy">Artimo, P. et al. ExPASy: SIB bioinformatics resource portal. ''Nucleic Acids Res'' '''40''', W597-603 (2012).</ref>. | PsiK is a native enzyme obtained from ''Psilocybe cubensis'', which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both 4-hydroxytryptamine and psilocin as substrates to yield norbaeocystin ('''Fig. 1''') and psilocybin ('''Fig. 2'''), respectively. In a native state, PsiK is a 362 amino acid protein (40.4 kDa) with a theoretical pI of 5.26 calculated with the ExPASy ProtParam tool<ref name="ExPASy">Artimo, P. et al. ExPASy: SIB bioinformatics resource portal. ''Nucleic Acids Res'' '''40''', W597-603 (2012).</ref>. | ||
− | [[Image:T--Sydney_Australia--PsiK_KEGG_rxn1.gif|frame|none|Fig. 1: Phosphorylation of 4-hydroxytryptamine to norbaeocystin, mediated by PsiK. The reaction is dependant upon ATP, and ADP is released as a by-product. Source: [https://www.genome.jp/dbget-bin/www_bget?reaction+R11933 KEGG] ]] | + | [[Image:T--Sydney_Australia--PsiK_KEGG_rxn1.gif|frame|none|'''Fig. 1''': Phosphorylation of 4-hydroxytryptamine to norbaeocystin, mediated by PsiK. The reaction is dependant upon ATP, and ADP is released as a by-product. Source: [https://www.genome.jp/dbget-bin/www_bget?reaction+R11933 KEGG] ]] |
− | [[Image:T--Sydney_Australia--PsiK_KEGG_rxn2.gif|frame|none|Fig. 2: Phosphorylation of psilocin to psilocybin, mediated by PsiK. The reaction is dependant upon ATP, and ADP is released as a by-product. Source: [https://www.genome.jp/dbget-bin/www_bget?reaction+R08480 KEGG] ]] | + | [[Image:T--Sydney_Australia--PsiK_KEGG_rxn2.gif|frame|none|'''Fig. 2''': Phosphorylation of psilocin to psilocybin, mediated by PsiK. The reaction is dependant upon ATP, and ADP is released as a by-product. Source: [https://www.genome.jp/dbget-bin/www_bget?reaction+R08480 KEGG] ]] |
Heterologous expression of PsiK has been achieved in a T7 induction system using pET-28c(+) transformed into ''Escherichia coli'' BL21(DE3), co-transformed with chaperone plasmid pGro7 ('''Fig. 3'''), resulting in a 397 amino acid polypeptide, with a computed molecular weight of 44.2 kDa. | Heterologous expression of PsiK has been achieved in a T7 induction system using pET-28c(+) transformed into ''Escherichia coli'' BL21(DE3), co-transformed with chaperone plasmid pGro7 ('''Fig. 3'''), resulting in a 397 amino acid polypeptide, with a computed molecular weight of 44.2 kDa. | ||
Line 27: | Line 27: | ||
[[Image:T--Sydney Australia--SDS soluble PsiDKM.png|900px|thumb|none|'''Fig. 4''': Polyacrylamide gel electrophoresis image of soluble protein extract from uninduced and IPTG induced ''E. coli'' BL21(DE3)::pGro7 cells containing pET-28c(+):PsiD, pET-28c(+):PsiK, and pET-28c(+):PsiM, run on an Mini-PROTEAN® TGX Stain-Free™ precast gel (Bio-Rad) at 120V for 60 minutes.]] | [[Image:T--Sydney Australia--SDS soluble PsiDKM.png|900px|thumb|none|'''Fig. 4''': Polyacrylamide gel electrophoresis image of soluble protein extract from uninduced and IPTG induced ''E. coli'' BL21(DE3)::pGro7 cells containing pET-28c(+):PsiD, pET-28c(+):PsiK, and pET-28c(+):PsiM, run on an Mini-PROTEAN® TGX Stain-Free™ precast gel (Bio-Rad) at 120V for 60 minutes.]] | ||
− | Activity of PsiK was confirmed with LC/MS. Protein extract from ''E. coli'' BL21(DE3) cells co-transformed with pET-28c(+):PsiK and pGro7 was subject to LC/MS, both with and without the addition of the | + | Activity of PsiK was confirmed with LC/MS. Protein extract from ''E. coli'' BL21(DE3) cells co-transformed with pET-28c(+):PsiK and pGro7 was subject to LC/MS, both with and without the addition of the PsiK substrate, 4-hydroxytryptamine. The PsiK product, norbaeocystin, was only identified in the sample to which 4-hydroxytryptamine was added, confirming the activity of PsiK ''in vitro'' ('''Table 1'''). |
− | + | ||
− | + | ||
While norbaeocystin was observed in the sample to which 4-hydroxytryptamine was added ('''Table 1'''), it was not observed when 4-hydroxytryptamine was absent ('''Table 2'''). | While norbaeocystin was observed in the sample to which 4-hydroxytryptamine was added ('''Table 1'''), it was not observed when 4-hydroxytryptamine was absent ('''Table 2'''). | ||
Line 95: | Line 93: | ||
|} | |} | ||
− | ''In vivo'' expression of | + | ''In vivo'' expression of PsiK was also confirmed. PsiD, PsiK, and PsiM were cloned into a pUS250 backbone as a gene cluster using Golden Gate cloning, yielding pUS387 ('''Fig. 5'''). Expression in pUS387 is driven by a class 1 integron gene cassette Pc promoter controlled by a cumate induction system. ''E. coli'' DH5α cells co-transformed with pUS387 and pGro7 were cultured in terrific broth (TB) supplemented with 4-hydroxytryptamine. Whole cell culture was subject to LC/MS. |
− | [[Image:T--Sydney_Australia--pUS387_map.png|700px|frame|none|'''Fig. | + | [[Image:T--Sydney_Australia--pUS387_map.png|700px|frame|none|'''Fig. 5''': pUS387 plasmid map, showing PsiD, PsiK, and PsiM genes organised in a cluster, driven by a class 1 integron gene cassette Pc promoter, flanked by CuO, a cumate repressor binding operator.]] |
{| class="wikitable" | {| class="wikitable" | ||
Line 157: | Line 155: | ||
|} | |} | ||
− | The | + | The ''in vivo'' activity of PsiK is confirmed by observation of PsiK product norbaeocystin ('''Fig. 6'''). |
+ | |||
+ | [[Image:T--Sydney_Australia--norbaeo16_387_lcms.png|frame|none|'''Fig. 6''': Mass spectra obtained LC/MS of protein extract of ''E. coli'' DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine. A peak at m/z = 257.06857 with chemical formula C10H14N2O4P was identified, matching PsiK product norbaeocystin.]] | ||
+ | |||
+ | Finally, confirmation of expression in pET-28c(+):PsiK was gained by gained by peptide mass fingerprinting ('''Fig. 7'''), which matched to PsiM with an identity score of 49 (0.00011 expected) and protein sequence coverage of 49%. | ||
− | [[Image:T--Sydney_Australia-- | + | [[Image:T--Sydney_Australia--peptide_gel.jpg|900px|thumb|none|'''Fig. 7''': Polyacrylamide gel containing soluble cell lysate profiles from pET-28c(+):PsiM and pET-28c(+):PsiK cultures believed to be expressing soluble PsiM and PsiK, stained with Coomassie Blue. The bands highlighted in red were cut, destained with 40% acetonitrile/60% 20mM ammonium bicarbonate. Cut bands were then dehydrated, and then rehydrated with 12ng/ul porcine trypsin at 4°C for 30min. Excess trypsin was removed and 10 μl of 20mM ammonium bicarbonate was added. Following overnight incubation at 37°C. Peptide masses were determined using mass spectroscopy, and samples were identified using a Mascot peptide mass fingerprint search.]] |
− | Given these results, we conclude that we have successfully expressed the | + | Given these results, we conclude that we have successfully expressed the 4-hydroxytryptamine kinase decarboxylase PsiK from ''Psilocybe cubensis'' in ''Escherichia coli'' both ''in vivo'' and ''in vitro''. |
<span class='h3bb'>'''Sequence and Features'''</span> | <span class='h3bb'>'''Sequence and Features'''</span> |
Latest revision as of 12:33, 21 October 2019
PsiK - 4-hydroxytryptamine kinase from Psilocybe cubensis
PsiK is a 4-hydroxytryptamine kinase, which catalyses the conversion of 4-hydroxytryptamine to norbaeocystin.
- NCBI: ASU62237.1
- UniProt: P0DPA8
- EC number: 2.7.1.222
Usage and Biology
The mechanism of psilocybin biosynthesis in Psilocybe sp. was recently elucidated by Fricke et al.[1], demonstrating that L-tryptophan proceeds through decarboxylation (mediated by PsiD), hydroxylation (mediated by PsiH), phosphorylation (mediated by PsiK), and finally N,N-dimethylation (mediated by PsiM) to yield psilocybin.
PsiK is a native enzyme obtained from Psilocybe cubensis, which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both 4-hydroxytryptamine and psilocin as substrates to yield norbaeocystin (Fig. 1) and psilocybin (Fig. 2), respectively. In a native state, PsiK is a 362 amino acid protein (40.4 kDa) with a theoretical pI of 5.26 calculated with the ExPASy ProtParam tool[2].
Heterologous expression of PsiK has been achieved in a T7 induction system using pET-28c(+) transformed into Escherichia coli BL21(DE3), co-transformed with chaperone plasmid pGro7 (Fig. 3), resulting in a 397 amino acid polypeptide, with a computed molecular weight of 44.2 kDa.
A band consistent with expression of PsiK in cells induced with IPTG was observed on polyacrylamide gel electrophoresis (Fig. 4).
Activity of PsiK was confirmed with LC/MS. Protein extract from E. coli BL21(DE3) cells co-transformed with pET-28c(+):PsiK and pGro7 was subject to LC/MS, both with and without the addition of the PsiK substrate, 4-hydroxytryptamine. The PsiK product, norbaeocystin, was only identified in the sample to which 4-hydroxytryptamine was added, confirming the activity of PsiK in vitro (Table 1).
While norbaeocystin was observed in the sample to which 4-hydroxytryptamine was added (Table 1), it was not observed when 4-hydroxytryptamine was absent (Table 2).
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
1.16 | 0.9 | 257.0687 | C10H14N2O4P | norbaeocystin |
2.63 | 20.7 | 177.1024 | C10H13N2O | hydroxytryptamine |
3.46 | 2.4 | 205.0972 | C11H13N2O2 | tryptophan |
10.14 | 5.1 | 285.1336 | C9H18N8OP | unknown |
10.14 | 5.1 | 285.1336 | C14H21O6 | unknown |
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
10.16 | 11.3 | 285.1336 | C14H21O6 | unknown |
10.16 | 11.3 | 285.1336 | C9H18N8OP | unknown |
In vivo expression of PsiK was also confirmed. PsiD, PsiK, and PsiM were cloned into a pUS250 backbone as a gene cluster using Golden Gate cloning, yielding pUS387 (Fig. 5). Expression in pUS387 is driven by a class 1 integron gene cassette Pc promoter controlled by a cumate induction system. E. coli DH5α cells co-transformed with pUS387 and pGro7 were cultured in terrific broth (TB) supplemented with 4-hydroxytryptamine. Whole cell culture was subject to LC/MS.
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
0.56 | 23.2 | 271.0817 | C12H15O7 | unknown |
1.16 | 12.4 | 257.0689 | C10H14N2O4P | norbaeocystin |
1.9 | 0.9 | 271.0844 | C11H16N2O4P | baeocystin |
2.75 | 5.2 | 177.1023 | C10H13N2O | hydroxytryptamine |
5.08 | 6.4 | 205.0972 | C11H13N2O2 | tryptophan |
5.82 | 6.4 | 161.1074 | C10H13N2 | tryptamine |
10.15 | 14.4 | 285.1335 | C14H21O6 | unknown |
10.15 | 14.4 | 285.1335 | C9H18N8OP | unknown |
The in vivo activity of PsiK is confirmed by observation of PsiK product norbaeocystin (Fig. 6).
Finally, confirmation of expression in pET-28c(+):PsiK was gained by gained by peptide mass fingerprinting (Fig. 7), which matched to PsiM with an identity score of 49 (0.00011 expected) and protein sequence coverage of 49%.
Given these results, we conclude that we have successfully expressed the 4-hydroxytryptamine kinase decarboxylase PsiK from Psilocybe cubensis in Escherichia coli both in vivo and in vitro.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 864
Illegal SapI.rc site found at 973